§ 13F · FUND PROFILE
VR ADVISER, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 27Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$2024.5T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | APGE | APOGEE THERAPEUTICS INC | 8.49M | $641.1T | 31.7% | NEW |
| 2 | ORKA | ORUKA THERAPEUTICS INC | 4.15M | $125.7T | 6.2% | NEW |
| 3 | VRDN | VIRIDIAN THERAPEUTICS INC | 3.88M | $120.8T | 6.0% | NEW |
| 4 | SYRE | SPYRE THERAPEUTICS INC | 3.69M | $120.7T | 6.0% | NEW |
| 5 | KALV | KALVISTA PHARMACEUTICALS INC | 6.73M | $108.7T | 5.4% | NEW |
| 6 | OCUL | OCULAR THERAPEUTIX INC | 7.32M | $88.8T | 4.4% | NEW |
| 7 | SVRA | SAVARA INC | 13.74M | $82.9T | 4.1% | NEW |
| 8 | COGT | COGENT BIOSCIENCES INC | 2.00M | $71.0T | 3.5% | NEW |
| 9 | ERAS | ERASCA INC | 17.86M | $66.4T | 3.3% | NEW |
| 10 | CTMX | CYTOMX THERAPEUTICS INC | 15.56M | $66.3T | 3.3% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE VR SIGNAL
AC read
VR ADVISER, LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed